Rehabilitation Center of The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510000, China.
First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510000.
Zhen Ci Yan Jiu. 2023 Nov 25;48(11):1095-1102. doi: 10.13702/j.1000-0607.20221165.
This study aims to explore the analgesic mechanism of fire needle on peripheral sensitization in rats with neuropathic pain(NP) induced by oxaliplatin, so as to investigate its mechanism in improving peri-pheral sensitization.
Male SD rats aged 8 weeks were randomly divided into 4 groups:normal group(=6), model group(=6), fire needle group(=6), and medication group(=6). NP rat model was established by intraperitoneal injection of oxaliplatin(4 mg/kg) on days 1, 2, 8, 9, 15, 16, 22, and 23. For rats in the fire needle group, fire needle treatment was performed at the "Jiaji"(EX-B2) acupoints of the L4-L6 segments on days 24, 26, and 28, ie. 1 day, 3 and 5 days after modeling. The medication group received intraperitoneal injection of pregabalin(100 mg/kg). Mechanical pain thresholds of the rats were measured before modeling, after modeling and intervention. Serum contents of tumor necrosis factor-α(TNF-α), interleukin-6(IL-6) and chemokine ligand 12(CXCL12) were detected by ELISA. Skin histopathology changes in the acupoint area were observed using HE staining. The number of mast cells in the skin of the acupoints was observed using toluidine blue staining. Immunohistochemical staining was performed to detect the postive expressions of transient receptor potential vanilloid 1(TRPV1), protease-activated receptor 2(PAR2) and tryptase(TPS) in the skin of the acupoint area. Western blot was used to detect the protein expressions of TRPV1 and PAR2 in the dorsal root ganglia(DRG).
Compared with the normal group, the model group had decreased paw withdrawal threshold(PWT) after modeling(<0.05), increased serum contents of IL-6, TNF-α, and CXCL12(<0.05), increased number of mast cells in the acupoint area(<0.05), and increased positive protein expressions of TPS, TRPV1, and PAR2 in the skin of the acupoint area(<0.05). Compared with the model group, the fire needle group and medication group had increased PWT after intervention(<0.05), decreased serum contents of IL-6, TNF-α, and CXCL12, and postive protein expressions of TPS, TRPV1, and PAR2 in the skin of the acupoint area(<0.05);while the medication group had decreased protein expressions of TRPV1 and PAR2 in DRG(<0.05). HE staining showed thickened epidermis, disordered cellular arrangement, significant intercellular edema, and inflammatory cell infiltration in the model group. In the medication and fire needle groups, the epidermis was thinner, cellular arrangement was clearer, and the extent of tissue edema and inflammatory cell infiltration was reduced compared to the model group.
Fire needle can improve mechanical pain threshold and reduce the contents of peripheral inflammatory factors in rats with oxaliplatin-induced NP. This effect may be related to the inhibition of mast cell activation and the inhibition of TPS, TRPV1 and PAR2 protein expressions, in the local areas of acupoints.
本研究旨在探讨火针对奥沙利铂诱导的神经病理性疼痛(NP)大鼠外周敏化的镇痛机制,以探讨其改善外周敏化的机制。
8 周龄雄性 SD 大鼠随机分为 4 组:正常组(n=6)、模型组(n=6)、火针组(n=6)和药物组(n=6)。第 1、2、8、9、15、16、22 和 23 天,腹腔注射奥沙利铂(4mg/kg)建立 NP 大鼠模型。造模后第 24、26 和 28 天,火针组大鼠在 L4-L6 节段的“夹脊”(EX-B2)穴位进行火针治疗,即造模后第 1、3 和 5 天。药物组大鼠腹腔注射普瑞巴林(100mg/kg)。在建模前、建模后和干预后测量大鼠的机械痛阈值。采用 ELISA 法检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和趋化因子配体 12(CXCL12)含量。采用 HE 染色观察穴位区皮肤组织病理学变化。甲苯胺蓝染色观察穴位皮肤中肥大细胞数量。免疫组织化学染色检测穴位区皮肤中瞬时受体电位香草酸 1(TRPV1)、蛋白酶激活受体 2(PAR2)和类胰蛋白酶(TPS)的阳性表达。Western blot 检测背根神经节(DRG)中 TRPV1 和 PAR2 的蛋白表达。
与正常组相比,模型组造模后 paw withdrawal threshold(PWT)降低(P<0.05),血清 IL-6、TNF-α和 CXCL12 含量升高(P<0.05),穴位区肥大细胞数量增多(P<0.05),穴位区皮肤中 TPS、TRPV1 和 PAR2 的阳性蛋白表达增加(P<0.05)。与模型组相比,火针组和药物组干预后 PWT 升高(P<0.05),血清 IL-6、TNF-α和 CXCL12 含量及穴位区皮肤中 TPS、TRPV1 和 PAR2 的阳性蛋白表达降低(P<0.05);药物组 DRG 中 TRPV1 和 PAR2 蛋白表达降低(P<0.05)。HE 染色显示模型组表皮增厚,细胞排列紊乱,细胞间水肿明显,炎症细胞浸润。药物组和火针组较模型组表皮变薄,细胞排列较清晰,组织水肿和炎症细胞浸润程度减轻。
火针可提高奥沙利铂诱导的 NP 大鼠的机械痛阈值,降低外周炎症因子含量。这种作用可能与抑制穴位局部肥大细胞激活和抑制 TPS、TRPV1 和 PAR2 蛋白表达有关。